Globus Medical
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers musculoskeletal solutions, including spine products, such as traditional fusion implants, and treatment options for motion preservation technologies, and interventional solutions to treat vertebral… Read more
Globus Medical (GMED) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.057x
Based on the latest financial reports, Globus Medical (GMED) has a cash flow conversion efficiency ratio of 0.057x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($249.69 Million) by net assets ($4.40 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Globus Medical - Cash Flow Conversion Efficiency Trend (2010–2024)
This chart illustrates how Globus Medical's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Globus Medical Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Globus Medical ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Toray Industries Inc
PINK:TRYIF
|
0.024x |
|
Tingyi (Cayman Islands) Holding Corp
PINK:TYCMY
|
0.097x |
|
Everest Group Ltd
NYSE:EG
|
-0.021x |
|
Applied Industrial Technologies Inc.
LSE:0HGR
|
N/A |
|
Anhui Jianghuai Automobile Group Corp Ltd
SHG:600418
|
0.066x |
|
Eurobank Ergasias Services and Holdings S.A
PINK:EGFEF
|
0.284x |
|
Scentre Group
PINK:STGPF
|
0.031x |
|
MPI Corporation
TWO:6223
|
-0.094x |
Annual Cash Flow Conversion Efficiency for Globus Medical (2010–2024)
The table below shows the annual cash flow conversion efficiency of Globus Medical from 2010 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $4.18 Billion | $520.64 Million | 0.125x | +104.63% |
| 2023-12-31 | $4.00 Billion | $243.50 Million | 0.061x | -36.99% |
| 2022-12-31 | $1.85 Billion | $178.47 Million | 0.097x | -39.07% |
| 2021-12-31 | $1.74 Billion | $276.27 Million | 0.159x | +20.21% |
| 2020-12-31 | $1.51 Billion | $198.79 Million | 0.132x | +7.63% |
| 2019-12-31 | $1.40 Billion | $171.97 Million | 0.123x | -19.97% |
| 2018-12-31 | $1.19 Billion | $181.64 Million | 0.153x | -7.05% |
| 2017-12-31 | $967.78 Million | $159.53 Million | 0.165x | -20.20% |
| 2016-12-31 | $832.08 Million | $171.89 Million | 0.207x | +21.17% |
| 2015-12-31 | $715.32 Million | $121.96 Million | 0.170x | +26.07% |
| 2014-12-31 | $585.45 Million | $79.17 Million | 0.135x | -31.66% |
| 2013-12-31 | $472.36 Million | $93.47 Million | 0.198x | -0.05% |
| 2012-12-31 | $386.50 Million | $76.52 Million | 0.198x | -26.81% |
| 2011-12-31 | $282.48 Million | $76.41 Million | 0.271x | -13.41% |
| 2010-12-31 | $228.19 Million | $71.29 Million | 0.312x | -- |